UBS O'Connor’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,635
Closed -$768K 650
2023
Q2
$839K Sell
14,635
-15,917
-52% -$831K 0.02% 400
2023
Q1
$1.15M Buy
+30,552
New +$1.13M 0.03% 390
2022
Q4
Sell
-36,534
Closed -$1.03M 445
2022
Q3
$1.03M Sell
36,534
-3,000
-8% -$83.6K 0.01% 744
2022
Q2
$858K Buy
+39,534
New +$1.1M 0.01% 781

Other funds holding MORF

UBS O'Connor's MORF Position: Q3 2023 in Review

UBS O'Connor sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2023, closing a stake of 14,635 shares — an estimated $768K sold.

UBS O'Connor first reported a position in MORF in Q2 2022 and held it in 4 quarters. The position peaked at $1.15M in Q1 2023. 134 funds tracked by Wall St. Rank hold MORF as of Q3 2023.

  • UBS O'Connor reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 14,635 Morphic Holding, Inc. Common Stock shares in Q3 2023, an estimated $768K.
  • UBS O'Connor first reported a position in Morphic Holding, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • UBS O'Connor's Morphic Holding, Inc. Common Stock position peaked at $1.15M in Q1 2023.
  • 134 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.